Table 1.
Total | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Stage 5 | |
---|---|---|---|---|---|---|
HbSS patients | 79 (100) | 14 (18) | 28 (35) | 33 (42) | 4 (5) | 0 (0) |
Proteinuria | 16 (20) | 2 (13) | 3 (19) | 7 (44) | 4 (25) | 0 (0) |
No proteinuria | 63 (80) | 12 (19) | 25 (40) | 26 (41) | 0 (0) | 0 (0) |
HbSC patientsa | 21 (100) | 3 (14) | 9 (43) | 9 (43) | 0 (0) | 0 (0) |
Age | ||||||
<24 years | 49 (100) | 9 (18) | 18 (37) | 21 (43) | 1 (2) | 0 (0) |
>24 years | 51 (100) | 8 (16) | 19 (37) | 21 (41) | 3 (6) | 0 (0) |
Figures denote the number of patients, with the percentage in parentheses.
None of the HbSC subjects had proteinuria.